Literature DB >> 22798508

Idiopathic membranoproliferative glomerulonephritis: does it exist?

Fernando C Fervenza1, Sanjeev Sethi, Richard J Glassock.   

Abstract

When membranoproliferative glomerulonephritis (MPGN) was first delineated as a discrete clinico-pathological entity more than a half-century ago, most cases were regarded as idiopathic (or primary) in nature. Advances in analysis of pathogenetic mechanisms and etiologies underlying the lesion of MPGN have radically altered the prevalence of the truly idiopathic form of MPGN. In addition, MPGN as a category among renal biopsies showing glomerulonephritis has diminished over time. In the modern era, MPGN is mainly classified morphologically on the basis of immunoglobulin (Ig; monoclonal or polyclonal) and complement (C3 only or combined with Ig) deposition and secondarily on the basis of its appearance on ultra-structural examination. Idiopathic MPGN is a diagnosis of exclusion, at least in many adults and a portion of children, and a systematic approach to evaluation will often uncover a secondary cause, such as an infection, autoimmune disease, monoclonal gammopathy, neoplasia, complement dysregulation or a chronic thrombotic microangiopathy. Idiopathic MPGN remains an 'endangered species' after its separation from these known causes.

Entities:  

Mesh:

Year:  2012        PMID: 22798508     DOI: 10.1093/ndt/gfs288

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  13 in total

1.  Characteristics of membranoproliferative glomerulonephritis based on a new classification at a single center.

Authors:  Marie Nakano; Kazunori Karasawa; Takahito Moriyama; Keiko Uchida; Kosaku Nitta
Journal:  Clin Exp Nephrol       Date:  2019-03-11       Impact factor: 2.801

Review 2.  Autoimmune abnormalities of the alternative complement pathway in membranoproliferative glomerulonephritis and C3 glomerulopathy.

Authors:  Marina Noris; Roberta Donadelli; Giuseppe Remuzzi
Journal:  Pediatr Nephrol       Date:  2018-06-09       Impact factor: 3.714

3.  Clusters Not Classifications: Making Sense of Complement-Mediated Kidney Injury.

Authors:  H Terence Cook; Matthew C Pickering
Journal:  J Am Soc Nephrol       Date:  2017-12-11       Impact factor: 10.121

Review 4.  Histopathology of MPGN and C3 glomerulopathies.

Authors:  H Terence Cook; Matthew C Pickering
Journal:  Nat Rev Nephrol       Date:  2014-12-02       Impact factor: 28.314

5.  Clinical features and pathogenesis of membranoproliferative glomerulonephritis: a nationwide analysis of the Japan renal biopsy registry from 2007 to 2015.

Authors:  Naoki Nakagawa; Naoyuki Hasebe; Motoshi Hattori; Michio Nagata; Hitoshi Yokoyama; Hiroshi Sato; Hitoshi Sugiyama; Akira Shimizu; Yoshitaka Isaka; Shoichi Maruyama; Ichiei Narita
Journal:  Clin Exp Nephrol       Date:  2017-12-06       Impact factor: 2.801

6.  Evolution of immunoglobulin deposition in C3-dominant membranoproliferative glomerulopathy.

Authors:  Eric Kerns; David Rozansky; Megan L Troxell
Journal:  Pediatr Nephrol       Date:  2013-07-28       Impact factor: 3.714

7.  The incidence of possible causes of membranoproliferative glomerulonephritis: a single-center experience.

Authors:  J Pavinic; M Miglinas
Journal:  Hippokratia       Date:  2015 Oct-Dec       Impact factor: 0.471

8.  Outcome of patients with primary immune-complex type mesangiocapillary glomerulonephritis (MCGN) in Cape Town South Africa.

Authors:  Ikechi G Okpechi; Thandiwe A L Dlamini; Maureen Duffield; Brian L Rayner; George Moturi; Charles R Swanepoel
Journal:  PLoS One       Date:  2014-11-20       Impact factor: 3.240

Review 9.  C3 glomerulopathy and atypical hemolytic uremic syndrome: an updated review of the literature on alternative complement pathway disorders.

Authors:  Kultigin Turkmen; Ismail Baloglu; Hakan Ozer
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

10.  Case Report of Spontaneous Remission of Biopsy-Proven Idiopathic Immune Complex-Mediated Membranoproliferative Glomerulonephritis.

Authors:  Rehan Shah; Mark S Segal; Michael J Wilkowski
Journal:  Case Rep Nephrol Dial       Date:  2017-06-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.